Accelerating global chemical product innovation and development

Scientific and regulatory support to market and sustain your products in any jurisdiction.

Competitive Advantage

Acta is a global scientific and regulatory consulting firm that assists companies that make and use chemicals with strategic commercialization planning and complex product registration and compliance matters.

We partner with our clients to help them get products quickly and efficiently to market — in any country or locale — and keep them there when challenged by a new regulatory regime, issue, or set of rules.

More About Us

Knowledge & Insights

  March 2, 2024
Global Regulatory Updates
Global Regulatory Update for March 2024

AUSTRALIA Final Guidance On Environmental Claims Includes Principles To Guide Business: On December 12, 2023, the Australian Competition and Consumer...

  March 26, 2024
PFAS – What to Know Now, and What to Expect

Perfluoroalkyl and polyfluoroalkyl substances (PFAS) are attracting global legal, regulatory, commercial, and litigation attention as no other...

  January 3, 2024
Forecast for U.S. Federal and International Chemical Regulatory Policy 2024

Click here for a PDF brochure of the memorandum Bergeson & Campbell, P.C. (B&C®) and its global consulting affiliate The Acta Group (Acta®)...

  April 5, 2024
EPA Proposes to Require Submission of Health and Safety Studies for 16 Chemicals Being Considered for TSCA Risk Evaluation

The U.S. Environmental Protection Agency (EPA) published on March 26, 2024, a proposed rule requiring manufacturers (including importers) of 16...

  March 28, 2024
EPA Bans Ongoing Uses of Asbestos

On March 28, 2024, the U.S. Environmental Protection Agency (EPA) issued a final rule under the Toxic Substances Control Act (TSCA) to address to the...

  March 21, 2024
EPA Issues Draft Risk Evaluation for Formaldehyde, Preliminarily Finds That Formaldehyde Poses Unreasonable Risk to Human Health

The U.S. Environmental Protection Agency (EPA) announced on March 15, 2024, the availability of and solicited public comment on the 2024 draft risk...

  March 7, 2024
EPA Releases New Methodology to Detect Low Levels of PFAS in HDPE Containers

On February 15, 2024, the U.S. Environmental Protection Agency (EPA) announced the release of a new methodology for detecting 32 per- and...

  March 5, 2024
EPA Amends Risk Management Program Requirements to Protect At-Risk Communities from Chemical Accidents

On March 1, 2024, the U.S. Environmental Protection Agency (EPA) released its “Safer Communities by Chemical Accident Prevention Rule” (SCCAP...

Seminars & Webinars

  March 21, 2024
Seminars & Webinars
HCPA 2024 Mid-Year Meeting, May 7-10, 2024, Washington, D.C.

HCPA’s Mid-Year Meeting focuses on the public policy issues that impact the household and commercial products industry. Thought leaders will...

  December 18, 2023
Seminars & Webinars
Harmonizing TSCA Consent Orders with OSHA HCS 2012, May 14, 2024, 11:00 a.m. – 12:00 p.m. (EDT), via webinar

Register now to join Bergeson & Campbell, P.C. (B&C®) and The Acta Group (Acta®) for “Harmonizing TSCA Consent Orders with OSHA HCS...

  April 12, 2024
Seminars & Webinars
Sponsors Role in Regulatory Testing, June 12, 2024, 11:00 a.m. – 12:00 p.m. (EDT), via webinar

B&C and Acta are pleased to present “Sponsors Role in Regulatory Testing.” More details will be posted closer to the webinar....

With offices in the U.S., UK, and Europe, and partners and agents in China, South Korea, Turkey, Mexico, and more, Acta offers expertise with regulatory programs and chemical product approvals in North America, Europe, South and Central America, and Asia.

Our Firms

our people

Experienced industry and agency scientists, including organic chemists, toxicologists, exposure experts, seven Ph.D.’s. Government affairs and regulatory specialists including nine high-level EPA alumni. Business strategists with decades of experience directing worldwide regulatory compliance.

Acta consultants manage products from concept to approval, delivering skills and experience with specific product areas in government and industry.

Our three affiliated firms -- B&C, Acta, and BCCM -- provide a full range of global support for the commercialization of chemicals, biocides, and products of industrial biotechnology, nanotechnology, and synthetic biology.